CELZ Stock Summary and Trading Ideas (Creative Medical Technology Holdings | NASDAQ:CELZ)

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Creative Medical Technology Holdings trades on the NASDAQ stock market under the symbol CELZ.

As of December 26, 2025, CELZ stock price declined to $2.10 with 55,403 million shares trading.

CELZ has a beta of 0.78, meaning it tends to be less sensitive to market movements. CELZ has a correlation of 0.02 to the broad based SPY ETF.

CELZ has a market cap of $7.34 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CELZ traded as high as $14.20 and as low as $1.69.

The top ETF exchange traded funds that CELZ belongs to (by Net Assets): VXF.

CELZ has underperformed the market in the last year with a price return of -9.5% while the SPY ETF gained +16.0%. CELZ has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -36.5% and -2.3%, respectively, while the SPY returned +4.6% and +1.5%, respectively.

CELZ support price is $2.09 and resistance is $2.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELZ shares will trade within this expected range on the day.